ID   KRJ-II
AC   CVCL_L295
DR   Wikidata; Q54900483
RX   PubMed=21544390;
CC   Population: Caucasian.
CC   Caution: The KRJ-I cell line established from the primary tumor of the same patient as KRJ-II was shown to be misidentified and to be an EBV-transformed lymphoblastoid cell line. As KRJ-II does not seem to have ever been distributed its status is uncertain.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C6422; Midgut neuroendocrine tumor G1
DI   ORDO; Orphanet_100093; Carcinoid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8886 ! KRJ-I
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
RX   PubMed=21544390; DOI=10.3892/ijo.8.3.513;
RA   Pfragner R., Wirnsberger G.H., Niederle B., Behmel A., Rinner I.,
RA   Mandl A., Wawrina F., Luo J.-S., Adamiker D., Hoger H., Ingolic E.,
RA   Schauenstein K.;
RT   "Establishment of a continuous cell line from a human carcinoid of the
RT   small intestine (KRJ-I).";
RL   Int. J. Oncol. 8:513-520(1996).
//